Hodgkin's lymphoma overview: Difference between revisions

Jump to navigation Jump to search
No edit summary
No edit summary
Line 6: Line 6:
'''Hodgkin's lymphoma''' is a type of [[lymphoma]] first described by [[Thomas Hodgkin]] in 1832. Hodgkin's lymphoma is characterized clinically by the orderly spread of disease from one [[lymph node]] group to another and by the development of [[B symptoms|systemic symptoms]] with advanced disease. Pathologically, the disease is characterized by the presence of [[Reed-Sternberg cell]]s. Hodgkin's lymphoma was one of the first [[cancer]]s to be cured by radiation. Later it was one of the first to be cured by  [[history of cancer chemotherapy#combination chemotherapy|combination chemotherapy]]. The cure rate is about 93%, making it one of the most curable forms of cancer.  
'''Hodgkin's lymphoma''' is a type of [[lymphoma]] first described by [[Thomas Hodgkin]] in 1832. Hodgkin's lymphoma is characterized clinically by the orderly spread of disease from one [[lymph node]] group to another and by the development of [[B symptoms|systemic symptoms]] with advanced disease. Pathologically, the disease is characterized by the presence of [[Reed-Sternberg cell]]s. Hodgkin's lymphoma was one of the first [[cancer]]s to be cured by radiation. Later it was one of the first to be cured by  [[history of cancer chemotherapy#combination chemotherapy|combination chemotherapy]]. The cure rate is about 93%, making it one of the most curable forms of cancer.  


==Diagnosis==
===Physical Examination===
Splenomegaly, or enlargement of the spleen, occurs in about 30% of people with Hodgkin's lymphoma. The enlargement, however, is seldom massive.  The liver may also be enlarged due to liver involvement in the disease in about 5% of cases.
===Laboratory Findings===
[[Blood test]]s are also performed to assess function of major organs and to assess safety for [[chemotherapy]].
===Chest X Ray===
The lymph nodes of the chest are often affected and these may be noticed on a chest x-ray.
===Other Imaging Findings ===
[[Positron emission tomography]] (PET) is used to detect small deposits that do not show on CT scanning.  In some cases a[[Gallium imaging|Gallium Scan]] may be used instead of a PET scan.
===Other Diagnostic Studies===
Hodgkin's lymphoma must be distinguished from non-cancerous causes of lymph node swelling (such as various infections) and from other types of cancer.  Definitive diagnosis is by lymph node [[biopsy]] (removal of a piece of lymph node tissue for pathological examination).
==Treatment==
===Medical Therapy===
Patients with early stage disease (IA or IIA) are effectively treated with [[radiation]] therapy or chemotherapy. The choice of treatment depends on the age, sex, bulk and the histological subtype of the disease. Patients with later disease (III, IVA, or IVB) are treated with combination chemotherapy alone.  Patients of any stage with a large mass in the chest are usually treated with combined chemotherapy and radiation therapy.
===Surgery===
Patients with Hodgkin's lymphoma have many treatment options. The selection depends on the stage of the disease. The options are radiation therapy, chemotherapy and high dose chemotherapy and bone marrow or peripheral blood stem cell transplant. Before treatment starts, ask your health care team about possible side effects and how treatment may change your normal activities. Because cancer treatments often damage healthy cells and tissues, side effects are common. [[Side effect]] may not be the same for each person, and they may change from one treatment session to the next.
===Primary Prevention===
Hodgkin's lymphoma is not related with life style, so there is no known risk factors for people to change at present. But more researches are needed to verify.
==References==
==References==
{{reflist|2}}
{{reflist|2}}
Line 15: Line 38:
[[Category:Oncology]]
[[Category:Oncology]]
[[Category:Mature chapter]]
[[Category:Mature chapter]]
 
[[Category:Primary care]]
{{WikiDoc Help Menu}}
{{WikiDoc Help Menu}}
{{WikiDoc Sources}}
{{WikiDoc Sources}}

Revision as of 19:36, 20 May 2013

Hodgkin's lymphoma Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Hodgkin's lymphoma from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

Staging

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X Ray Findings

CT

MRI

Ultrasound

Biopsy

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Hodgkin's lymphoma overview On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Hodgkin's lymphoma overview

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Hodgkin's lymphoma overview

CDC on Hodgkin's lymphoma overview

Hodgkin's lymphoma overview in the news

Blogs on Hodgkin's lymphoma overview

Directions to Hospitals Treating Hodgkin's lymphoma

Risk calculators and risk factors for Hodgkin's lymphoma overview

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Overview

Hodgkin's lymphoma is a type of lymphoma first described by Thomas Hodgkin in 1832. Hodgkin's lymphoma is characterized clinically by the orderly spread of disease from one lymph node group to another and by the development of systemic symptoms with advanced disease. Pathologically, the disease is characterized by the presence of Reed-Sternberg cells. Hodgkin's lymphoma was one of the first cancers to be cured by radiation. Later it was one of the first to be cured by combination chemotherapy. The cure rate is about 93%, making it one of the most curable forms of cancer.

Diagnosis

Physical Examination

Splenomegaly, or enlargement of the spleen, occurs in about 30% of people with Hodgkin's lymphoma. The enlargement, however, is seldom massive. The liver may also be enlarged due to liver involvement in the disease in about 5% of cases.

Laboratory Findings

Blood tests are also performed to assess function of major organs and to assess safety for chemotherapy.

Chest X Ray

The lymph nodes of the chest are often affected and these may be noticed on a chest x-ray.

Other Imaging Findings

Positron emission tomography (PET) is used to detect small deposits that do not show on CT scanning. In some cases aGallium Scan may be used instead of a PET scan.

Other Diagnostic Studies

Hodgkin's lymphoma must be distinguished from non-cancerous causes of lymph node swelling (such as various infections) and from other types of cancer. Definitive diagnosis is by lymph node biopsy (removal of a piece of lymph node tissue for pathological examination).

Treatment

Medical Therapy

Patients with early stage disease (IA or IIA) are effectively treated with radiation therapy or chemotherapy. The choice of treatment depends on the age, sex, bulk and the histological subtype of the disease. Patients with later disease (III, IVA, or IVB) are treated with combination chemotherapy alone. Patients of any stage with a large mass in the chest are usually treated with combined chemotherapy and radiation therapy.

Surgery

Patients with Hodgkin's lymphoma have many treatment options. The selection depends on the stage of the disease. The options are radiation therapy, chemotherapy and high dose chemotherapy and bone marrow or peripheral blood stem cell transplant. Before treatment starts, ask your health care team about possible side effects and how treatment may change your normal activities. Because cancer treatments often damage healthy cells and tissues, side effects are common. Side effect may not be the same for each person, and they may change from one treatment session to the next.

Primary Prevention

Hodgkin's lymphoma is not related with life style, so there is no known risk factors for people to change at present. But more researches are needed to verify.

References

Template:WikiDoc Sources